Analysts’ Top Healthcare Picks: STML, BPTH

By Jason Carr

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stemline Therapeutics Inc (NASDAQ: STML) and Bio-Path Holdings (NASDAQ: BPTH) with bullish sentiments.

Stemline Therapeutics Inc (NASDAQ: STML)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Stemline Therapeutics Inc (NASDAQ: STML) today and set a price target of $34. The company’s shares opened today at $8.30.

According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of -6.2% and a 37.0% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as RegeneRx Biopharmaceuticals Inc, Biospecifics Technologies Corp, and HTG Molecular Diagnostics.

Currently, the analyst consensus on Stemline Therapeutics Inc is Strong Buy and the average price target is $25.50, representing a 207.2% upside.

In a report issued on May 12, Cowen & Co. also reiterated a Buy rating on the stock.
Bio-Path Holdings (NASDAQ: BPTH)

Maxim Group analyst Jason McCarthy reiterated a Buy rating on Bio-Path Holdings (NASDAQ: BPTH) today and set a price target of $2. The company’s shares opened today at $0.54, close to its 52-week low of $0.53.

McCarthy wrote:

“Bio-Path reported 1Q17 with operating expenses of $2M which were offset by a change in non-cash warrant liability for a net loss of $0.4M. Bio-Path ended the period with $7.1M in cash, sufficient runway to the end of the year.”

According to TipRanks.com, McCarthy is ranked 0 out of 5 stars with an average return of -11.5% and a 37.4% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as ImmunoCellular Therapeutics, Mateon Therapeutics Inc, and Stellar Biotechnologies.

Bio-Path Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $3.25.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.